Treatment of SARS-CoV-2 infection with a new antiviral drug, MK-4482/EIDD-2801 or Molnupiravir, completely suppresses virus transmission within 24 hours, researchers in the Institute for Biomedical Sciences at Georgia State University have discovered.
source https://www.pharmatutor.org/pharma-news/2020/molnupiravir-oral-drug-blocks-sars-cov-2-transmission
No comments:
Post a Comment